Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
80.8M
-
Number of holders
-
94
-
Total 13F shares, excl. options
-
22.2M
-
Shares change
-
+2.59M
-
Total reported value, excl. options
-
$862M
-
Value change
-
+$92.7M
-
Number of buys
-
53
-
Number of sells
-
-29
-
Price
-
$38.86
Significant Holders of Kymera Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KYMR) as of Q1 2021
100 filings reported holding KYMR - Kymera Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q1 2021.
Kymera Therapeutics, Inc. - Common Stock, $0.0001 par value per share (KYMR) has 94 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.2M shares
of 80.8M outstanding shares and own 27.47% of the company stock.
Largest 10 shareholders include BVF INC/IL (2.63M shares), Redmile Group, LLC (2.6M shares), FMR LLC (2.35M shares), BAKER BROS. ADVISORS LP (1.96M shares), VANGUARD GROUP INC (1.73M shares), Deer IX & Co. Ltd. (1.66M shares), BlackRock Inc. (1.51M shares), STATE STREET CORP (937K shares), PRICE T ROWE ASSOCIATES INC /MD/ (933K shares), and WELLINGTON MANAGEMENT GROUP LLP (669K shares).
This table shows the top 94 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.